University of New Mexico Cancer Center Support

新墨西哥大学癌症中心支持

• 批准号: 7498738
• 负责人: CHERYL LYNN WILLMAN
• 金额: $ 5.68万
• 依托单位: UNIVERSITY OF NEW MEXICO
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-26 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7498738
• 关键词: American Indians; Behavioral; Cancer Biology; Cancer Center; Cancer Center Planning Grant; Cancer Center Support Grant; Caring; Cessation of life; Characteristics; Clinic; Clinical Trials; Clinical Trials Network; Communities; Community Networks; Development; Direct Costs; Funding; Genetic; Goals; Health; Healthcare Systems; Hematologic Neoplasms; Hispanics; Improve Access; Incidence; Innovative Therapy; Intervention Studies; Joints; Laboratories; Malignant Neoplasms; Mexican; Minority; Mission; New Mexico; Newly Diagnosed; Numbers; Patient Participation; Patients; Pattern; Peer Review; Population; Prevention; Prevention program; Protocols documentation; Provider; Rate; Research; Research Institute; SEER Program; Scientist; Screening procedure; Specialist; Therapeutic; Therapeutic Studies; Tribes; Underrepresented Minority; Underserved Population; United States Indian Health Service; Universities; Woman; anticancer research; cancer care; cancer education; cancer epidemiology; cancer health disparity; cancer therapy; cancer type; community based participatory research; cost; ethnic minority population; member; model development; mortality; multidisciplinary; prevention clinical trial; programs; ranpirnase; respiratory; social; socioeconomics; treatment center

Located in a region of rich multicultural and multiethnic diversity, tremendous scientific and technological capability, and challenging health and socioeconomic disparity, The University of New Mexico Cancer Research and Treatment Center (UNM CRTC) is uniquely poised to make significant contributions to the Nation's mission to reduce cancer incidence and eliminate death and suffering from cancer. The special characteristics of the UNM CRTC are the multiethnic populations that it serves with their strikingly different patterns of cancer incidence and mortality, the integration of regional scientific and technologic strengths into its Research Programs, and the extensive networks and partnerships that it has developed for participatory community-based research. Funded by a NCI P20 Cancer Center Planning Grant since 9/1/2000, the Center has made tremendous progress. With significant institutional, State, and community support, the CRTC has hired 36 new cancer specialists and scientists; doubled its annual NCI ($9,730,273 in direct costs + $2,004,977 in direct costs to the UNM NCI SEER program) and total peer-reviewed cancer funding ($25,257,828 in direct and $35,517,100 in total costs); formalized consortium arrangements with the Lovelace Respiratory Research Institute (LRRI) and partnerships with Sandia National Laboratory; doubled the number of newly diagnosed patients treated at the CRTC; significantly increased patient participation in clinical trials (35% of all patients were accrued to intervention studies, 13% to therapeutic studies); and maintained very high rates of care to underserved and minority patients (in a State where 33% of cancer cases occur in ethnic minorities, 52% of the patients treated at the UNM CRTC were minorities; minority accrual to all types of cancer protocols was 52% and 38% to therapeutic studies). The 91 Members of the UNM CRTC are clustered into 4 Research Programs: Cancer Epidemiology and Prevention, Cancer Biology, Hematologic Malignancies, and Women's Cancers that are focused on the following overall goals: 1. To conduct outstanding multidisciplinary and trandisciplinary cancer research in our laboratories, clinics, and communities that builds on unique institutional and regional scientific strengths and collaborative research partnerships with the Lovelace Respiratory Research Institute and New Mexico's National Laboratories. 2. To reduce cancer incidence and mortality by discovering the genetic, environmental, social, and behavioral factors that contribute to the distinct cancer patterns in the multiethnic populations of New Mexico. 3. To reduce cancer health disparities in the historically underserved populations of the Southwest through collaborative community networks with the State Department of Health; New Mexico Pueblos, Tribes, and American Indian Nations; the Indian Health Service; and local communities by developing culturally appropriate cancer education, screening, and prevention programs. 4. To provide outstanding cancer treatment for all New Mexicans, by improving access to quality cancer care and innovative therapies through increased referrals and formal affiliations with community cancer care providers. 5. To increase access to and participation of New Mexicans in cancer clinical investigations and cancer therapeutic and prevention clinical trials, facilitated by a joint UNM-community collaborative clinical trials network (The New Mexico Cancer Care Alliance).

位于丰富的多元文化和多种族多样性的地区，巨大的科学和技术能力以及 挑战健康和社会经济差异，新墨西哥大学癌症研究与治疗中心 （UNM CRTC）独特地准备为减少癌症发病率的国家的使命做出重大贡献 并消除死亡和患有癌症的痛苦。 UNM CRTC的特殊特征是多民族 它以极大不同的癌症发生率和死亡率的方式，整合的种群 其研究计划以及广泛的网络和伙伴关系的区域科学和技术优势 它已经为基于社区的研究而发展。由NCI P20癌症中心计划赠款资助 自2000年9月1日以来，该中心取得了巨大进展。在机构，州和社区的大量支持下， CRTC聘请了36位新的癌症专家和科学家。年度NCI翻了一番（直接成本为9,730,273美元 + UNM NCI SEER计划的直接成本为$ 2,004,977）和经过同行评审的癌症资金（25,257,828美元 直接和35,517,100美元的总成本）；与Lovelace呼吸研究的形式化财团安排 研究所（LRRI）和与桑迪亚国家实验室的合作伙伴关系；新诊断的患者数量增加了一倍 在CRTC治疗；患者参与临床试验的明显增加（所有患者中有35％均被计入 干预研究，治疗研究13％）；并保持非常高的服务率和少数族裔的护理率 患者（在少数民族中发生33％的癌症病例的州，有52％的患者在UNM中接受治疗 CRTC是少数民族；对所有类型的癌症方案的少数群体占治疗研究的52％和38％）。这 91个UNM CRTC成员聚集在4个研究计划中：癌症流行病学和预防， 癌症生物学，血液学恶性肿瘤和妇女癌症的重点是以下总体目标： 1。在我们的实验室，诊所和 建立在独特的机构和区域科学优势和协作研究的社区 与Lovelace呼吸研究所和新墨西哥州国家实验室的合作伙伴关系。 2。通过发现遗传，环境，社会和行为因素来降低癌症的发病率和死亡率 这有助于新墨西哥州多种族人口中不同的癌症模式。 3。通过减少西南历史欠佳人口中的癌症健康差异 与州卫生部的合作社区网络；新墨西哥州普韦布洛斯，部落和美国 印度国家；印度卫生服务局；和当地社区通过发展文化适当的癌症 教育，筛查和预防计划。 4。通过改善获得优质癌症护理的机会，为所有新墨西哥州提供出色的癌症治疗 通过增加推荐和与社区癌症护理提供者的正式隶属关系的创新疗法。 5。增加新墨西哥州参与癌症临床研究和癌症治疗的机会 和预防临床试验，由联合社区合作临床试验网络（新的）促进 墨西哥癌症护理联盟）。